TY - JOUR
T1 - The value of innovation in decision-making in health care in Central Eastern Europe
T2 - The sixth international conference, 2 June 2017, Belgrade, Serbia
AU - Novakovic, Tanja
AU - Martin, Antony P.
AU - Parker, Mark
AU - Ferrario, Alessandra
AU - Vukovic, Simo
AU - Łanda, Krzysztof
AU - Duba, Jaroslav
AU - Dankó, Dávid
AU - Kotsopoulos, Nikolaos
AU - Godman, Brian
AU - Ristic, Jelena
AU - Stefanovic, Danka
AU - Tesic, Danka
PY - 2017/12/31
Y1 - 2017/12/31
N2 - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
AB - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
KW - managed entry agreements
KW - health technology assessment
KW - innovation
KW - Central and Eastern Europe
UR - http://www.tandfonline.com/loi/ierp
U2 - 10.1080/14737167.2017.1385394
DO - 10.1080/14737167.2017.1385394
M3 - Article
VL - 17
SP - 519
EP - 521
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
SN - 1473-7167
IS - 6
ER -